SINOPHARM GROUP 1/5/O.N. (X2S1) — Defensive Interval Ratio
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Defensive Interval Ratio of 288 days as of December 2025. Defensive assets of €194.61 Billion (cash €-, short-term investments €129.00K, receivables €194.61 Billion) cover 288 days of daily cash needs of €675.96 Million/day. Check X2S1 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SINOPHARM GROUP 1/5/O.N. Defensive Interval Ratio (2021–2025)
This chart shows how SINOPHARM GROUP 1/5/O.N.'s Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 288 days, meaning defensive assets of €194.61 Billion can fund 288 days of operations without new revenue. Also explore X2S1 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for SINOPHARM GROUP 1/5/O.N. (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is SINOPHARM GROUP 1/5/O.N. worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 288 days | €194.61 Billion | €675.96 Million/day | €- | €129.00K | ▲ +14 days |
| 2024 | 274 days | €187.64 Billion | €685.96 Million/day | €- | €158.00K | ▲ +18 days |
| 2023 | 255 days | €169.00 Billion | €661.62 Million/day | €- | €547.00K | ▲ +14 days |
| 2022 | 242 days | €155.58 Billion | €643.73 Million/day | €- | €498.00K | ▼ -27 days |
| 2021 | 269 days | €161.41 Billion | €600.84 Million/day | €- | €11.75 Million | — |